Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants - Poll - MDSpire

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

  • By

  • Nicholas A. Marston

  • Shinwan Kany

  • Giorgio E. M. Melloni

  • Sean J. Jurgens

  • Frederick K. Kamanu

  • Yi-Pin Lai

  • Joel T. Rämö

  • Itamar Raz

  • Stephen D. Wiviott

  • Patrick T. Ellinor

  • Marc S. Sabatine

  • Christian T. Ruff

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

  • by Nicholas A. Marston, Shinwan Kany, Giorgio E. M. Melloni, Sean J. Jurgens, Frederick K. Kamanu, Yi-Pin Lai, Joel T. Rämö, Itamar Raz, Stephen D. Wiviott, Patrick T. Ellinor, Marc S. Sabatine, Christian T. Ruff

  • June 8, 2026

Related Content

Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy: a systematic review and meta-analysis

Analysis of factors associated with cognitive impairment in elderly patients hospitalized with chronic heart failure

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention